BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berth-Jones J, Exton LS, Ladoyanni E, Mohd Mustapa MF, Tebbs VM, Yesudian PD, Levell NJ. British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018. Br J Dermatol 2019;180:1312-38. [PMID: 30653672 DOI: 10.1111/bjd.17587] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Karadag AS, Aslan Kayıran M, Lotti T, Wollina U. Immunosuppressive and immunomodulator therapy for rare or uncommon skin disorders in pandemic days. Dermatol Ther 2020;33:e13686. [PMID: 32458530 DOI: 10.1111/dth.13686] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Hossain MF, Hasana S, Mamun AA, Uddin MS, Wahed MII, Sarker S, Behl T, Ullah I, Begum Y, Bulbul IJ, Amran MS, Rahman MH, Bin-Jumah MN, Alkahtani S, Mousa SA, Aleya L, Abdel-Daim MM. COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management. Front Pharmacol 2020;11:563478. [PMID: 33178016 DOI: 10.3389/fphar.2020.563478] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
3 O'Connor C, Dhonncha EN, Murphy M. "His first word was 'cream'." The burden of treatment in pediatric atopic dermatitis-A mixed methods study. Dermatol Ther 2021;:e15273. [PMID: 34914164 DOI: 10.1111/dth.15273] [Reference Citation Analysis]
4 Amber T, Tabassum S. Cyclosporin in dermatology: A practical compendium. Dermatol Ther 2020;33:e13934. [PMID: 32602210 DOI: 10.1111/dth.13934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sun HY, Keller E, Suresh H, Sebaratnam DF. Biologics for severe, chronic plaque psoriasis: An Australian cost-utility analysis. JAAD Int 2021;5:1-8. [PMID: 34816130 DOI: 10.1016/j.jdin.2021.06.004] [Reference Citation Analysis]
6 Ibrahim S, Amer A, Nofal H, Abdellatif A. Practical compendium for psoriasis management. Dermatol Ther 2020;33:e13243. [PMID: 32022374 DOI: 10.1111/dth.13243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wang C, Rademaker M, Baker C, Foley P. COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement. Australas J Dermatol 2020;61:210-6. [PMID: 32255510 DOI: 10.1111/ajd.13313] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 16.5] [Reference Citation Analysis]
8 Pandey S, Tripathi P, Gupta A, Yadav JS. A comprehensive review on possibilities of treating psoriasis using dermal cyclosporine. Drug Deliv Transl Res 2021. [PMID: 34550552 DOI: 10.1007/s13346-021-01059-5] [Reference Citation Analysis]
9 Cardinale F, Ciprandi G, Barberi S, Bernardini R, Caffarelli C, Calvani M, Cavagni G, Galli E, Minasi D, Del Giudice MM, Moschese V, Novembre E, Paravati F, Peroni DG, Tosca MA, Traina G, Tripodi S, Marseglia GL; and the SIAIP Task Force. Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic. Ital J Pediatr 2020;46:84. [PMID: 32546234 DOI: 10.1186/s13052-020-00843-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
10 Değirmenci MFK, Yalçındağ FN, Tugal-Tutkun İ. COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology. Turk J Ophthalmol 2021;51:231-42. [PMID: 34461710 DOI: 10.4274/tjo.galenos.2021.68252] [Reference Citation Analysis]
11 Su HJ, Chen CB, Yeh TY, Chung WH. Successful treatment of corticosteroid-dependent drug reaction with eosinophilia and systemic symptoms with cyclosporine. Ann Allergy Asthma Immunol 2021:S1081-1206(21)00570-6. [PMID: 34400311 DOI: 10.1016/j.anai.2021.08.012] [Reference Citation Analysis]
12 Hafouda Y, Sharma A, Li V, Yesudian PD. Double trouble: ciclosporin-simvastatin coinduced rhabdomyolysis. BMJ Case Rep 2019;12:e225971. [PMID: 31772127 DOI: 10.1136/bcr-2018-225971] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]